ReviewBioengineering (Basel, Switzerland)2025
Artificial Intelligence-Assisted Dermatologic Screening: Epidemiology and Clinical Features of Basal Cell Carcinoma, Squamous Cell Carcinoma, Seborrheic Keratosis and Actinic Keratosis.
Review in Bioengineering (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Article
- Overview of Aging, Skin Health, Estrogen, Menopause and HRT.Life (Basel, Switzerland) · 2026Article
- Review
- High-frequency ultrasound combined with superb microvascular imaging for differential diagnosis of basal cell carcinoma and seborrheic keratosis: a retrospective analysis with nomogram implementation.Frontiers in medicine · 2026Article
- Skin tumor identification by means of convolutional neural network and improved gray wolf optimizer.Frontiers in oncology · 2026Article
- An update on the diagnosis and treatment of seborrheic keratosis.Frontiers in medicine · 2026Review
- Global trends and academic landscapes of AI applications in basal cell carcinoma research: a bibliometric analysis.Frontiers in oncology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
This literature review synthesizes contemporary evidence regarding the epidemiology, screening guidelines, clinical manifestations, and machine-learning solutions for four prevalent non-melanoma skin lesions: basal cell carcinoma (BCC), squamous cell carcinoma (SCC), seborrheic keratosis (SK), and actinic keratosis (AK). This study presents a summary of common indices and recent screening alternatives, accompanied by a critical assessment of contemporary advancements in artificial intelligence (AI) and machine learning (ML) for the identification and classification of images utilizing standardized benchmark databases. The literature search and selection focused on peer-reviewed studies published from 2018 to December 2024, emphasizing diagnostic performance, datasets, preprocessing methodologies, and assessment metrics. This work compares and contextualizes reported results, highlighting the challenges posed by different study designs and biases in datasets that hinder direct comparisons among studies. The consistency of deep learning classifiers in lesion detection, the significance of sensitivity-oriented thresholding for early detection applications, and challenges associated with class imbalance and the under-representation of darker skin tones in publicly accessible datasets are studied. With practical implications for clinical adoption, emphasizing targeted screening of at-risk populations, the supplementary benefits of dermoscopy and the imperative for multi-center, demographically diverse validation have been concluded. Additionally, future research on standardized reporting, external validation, and interpretable, workflow-compatible AI systems has been proposed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.